1.Research Methodology
1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation
1.5.1.Top-down approach
1.5.2.Bottom-up approach
2.Report Scope
2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on global blood stream infection testing market
3.Executive Summary
4.Market Overview
4.1.Introduction
4.2.Growth impact forces
4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities
4.3.Market value chain analysis
4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors
4.4.Innovation & sustainability matrices
4.4.1.Technology matrix
4.4.2.Regulatory matrix
4.5.Porter’s five forces analysis
4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity
4.6.PESTLE analysis
4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental
4.7.Impact of COVID-19 on blood stream infection testing market
4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario
5.Blood Stream Infection Testing Market Analysis, by Product
5.1.Overview
5.2.Consumables
5.2.1.Definition, key trends, growth factors, and opportunities, 2021-2030
5.2.2.Market size analysis, by region, 2021-2030
5.2.3.Market share analysis, by country, 2021-2030
5.3.Instruments
5.3.1.Definition, key trends, growth factors, and opportunities, 2021-2030
5.3.2.Market size analysis, by region, 2021-2030
5.3.3.Market share analysis, by country, 2021-2030
5.4.Software & Services
5.4.1.Definition, key trends, growth factors, and opportunities, 2021-2030
5.4.2.Market size analysis, by region, 2021-2030
5.4.3.Market share analysis, by country, 2021-2030
5.5.Research Dive Exclusive Insights
5.5.1.Market attractiveness, 2021-2030
5.5.2.Competition heatmap, 2021-2030
6.Blood Stream Infection Testing Market Analysis, by Technique
6.1.Conventional
6.1.1.Definition, key trends, growth factors, and opportunities, 2021-2030
6.1.2.Market size analysis, by region, 2021-2030
6.1.3.Market share analysis, by country, 2021-2030
6.2.Automated
6.2.1.Definition, key trends, growth factors, and opportunities, 2021-2030
6.2.2.Market size analysis, by region, 2021-2030
6.2.3.Market share analysis, by country, 2021-2030
6.3.Research Dive Exclusive Insights
6.3.1.Market attractiveness, 2021-2030
6.3.2.Competition heatmap, 2021-2030
7.Blood Stream Infection Testing Market Analysis, by Technology
7.1.Culture-based
7.1.1.Definition, key trends, growth factors, and opportunities, 2021-2030
7.1.2.Market size analysis, by region, 2021-2030
7.1.3.Market share analysis, by country, 2021-2030
7.2.Molecular
7.2.1.Definition, key trends, growth factors, and opportunities, 2021-2030
7.2.2.Market size analysis, by region, 2021-2030
7.2.3.Market share analysis, by country, 2021-2030
7.3.Proteomic
7.3.1.Definition, key trends, growth factors, and opportunities, 2021-2030
7.3.2.Market size analysis, by region, 2021-2030
7.3.3.Market share analysis, by country, 2021-2030
7.4.Research Dive Exclusive Insights
7.4.1.Market attractiveness, 2021-2030
7.4.2.Competition heatmap, 2021-2030
8.Blood Stream Infection Testing Market Analysis, by Application
8.1.Bacterial
8.1.1.Definition, key trends, growth factors, and opportunities, 2021-2030
8.1.2.Market size analysis, by region, 2021-2030
8.1.3.Market share analysis, by country, 2021-2030
8.2.Fungal
8.2.1.Definition, key trends, growth factors, and opportunities, 2021-2030
8.2.2.Market size analysis, by region, 2021-2030
8.2.3.Market share analysis, by country, 2021-2030
8.3.Mycobacterial
8.3.1.Definition, key trends, growth factors, and opportunities, 2021-2030
8.3.2.Market size analysis, by region, 2021-2030
8.3.3.Market share analysis, by country, 2021-2030
8.4.Research Dive Exclusive Insights
8.4.1.Market attractiveness, 2021-2030
8.4.2.Competition heatmap, 2021-2030
9.Blood Stream Infection Testing Market Analysis, by End-user
9.1.Hospitals
9.1.1.Definition, key trends, growth factors, and opportunities, 2021-2030
9.1.2.Market size analysis, by region, 2021-2030
9.1.3.Market share analysis, by country, 2021-2030
9.2.Independent Diagnostics Centers
9.2.1.Definition, key trends, growth factors, and opportunities, 2021-2030
9.2.2.Market size analysis, by region, 2021-2030
9.2.3.Market share analysis, by country, 2021-2030
9.3.Others
9.3.1.Definition, key trends, growth factors, and opportunities, 2021-2030
9.3.2.Market size analysis, by region, 2021-2030
9.3.3.Market share analysis, by country, 2021-2030
9.4.Research Dive Exclusive Insights
9.4.1.Market attractiveness, 2021-2030
9.4.2.Competition heatmap, 2021-2030
10.Blood Stream Infection Testing Market, by Region
10.1.North America
10.1.1.U.S.
10.1.1.1.Market size analysis, by Product, 2021-2030
10.1.1.2.Market size analysis, by Technique, 2021-2030
10.1.1.3.Market size analysis, by Technology, 2021-2030
10.1.1.4.Market size analysis, by Application, 2021-2030
10.1.1.5.Market size analysis, by End-user, 2021-2030
10.1.2.Canada
10.1.2.1.Market size analysis, by Product, 2021-2030
10.1.2.2.Market size analysis, by Technique, 2021-2030
10.1.2.3.Market size analysis, by Technology, 2021-2030
10.1.2.4.Market size analysis, by Application, 2021-2030
10.1.2.5.Market size analysis, by End-user, 2021-2030
10.1.3.Mexico
10.1.3.1.Market size analysis, by Product, 2021-2030
10.1.3.2.Market size analysis, by Technique, 2021-2030
10.1.3.3.Market size analysis, by Technology, 2021-2030
10.1.3.4.Market size analysis, by Application, 2021-2030
10.1.3.5.Market size analysis, by End-user, 2021-2030
10.1.4.Research Dive Exclusive Insights
10.1.4.1.Market attractiveness, 2021-2030
10.1.4.2.Competition heatmap, 2021-2030
10.2.Europe
10.2.1.Germany
10.2.1.1.Market size analysis, by Product, 2021-2030
10.2.1.2.Market size analysis, by Technique, 2021-2030
10.2.1.3.Market size analysis, by Technology, 2021-2030
10.2.1.4.Market size analysis, by Application, 2021-2030
10.2.1.5.Market size analysis, by End-user, 2021-2030
10.2.2.U.K.
10.2.2.1.Market size analysis, by Product, 2021-2030
10.2.2.2.Market size analysis, by Technique, 2021-2030
10.2.2.3.Market size analysis, by Technology, 2021-2030
10.2.2.4.Market size analysis, by Application, 2021-2030
10.2.2.5.Market size analysis, by End-user, 2021-2030
10.2.3.France
10.2.3.1.Market size analysis, by Product, 2021-2030
10.2.3.2.Market size analysis, by Technique, 2021-2030
10.2.3.3.Market size analysis, by Technology, 2021-2030
10.2.3.4.Market size analysis, by Application, 2021-2030
10.2.3.5.Market size analysis, by End-user, 2021-2030
10.2.4.Spain
10.2.4.1.Market size analysis, by Product, 2021-2030
10.2.4.2.Market size analysis, by Technique, 2021-2030
10.2.4.3.Market size analysis, by Technology, 2021-2030
10.2.4.4.Market size analysis, by Application, 2021-2030
10.2.4.5.Market size analysis, by End-user, 2021-2030
10.2.5.Italy
10.2.5.1.Market size analysis, by Product, 2021-2030
10.2.5.2.Market size analysis, by Technique, 2021-2030
10.2.5.3.Market size analysis, by Technology, 2021-2030
10.2.5.4.Market size analysis, by Application, 2021-2030
10.2.5.5.Market size analysis, by End-user, 2021-2030
10.2.6.Rest of Europe
10.2.6.1.Market size analysis, by Product, 2021-2030
10.2.6.2.Market size analysis, by Technique, 2021-2030
10.2.6.3.Market size analysis, by Technology, 2021-2030
10.2.6.4.Market size analysis, by Application, 2021-2030
10.2.6.5.Market size analysis, by End-user, 2021-2030
10.2.7.Research Dive Exclusive Insights
10.2.7.1.Market attractiveness, 2021-2030
10.2.7.2.Competition heatmap, 2021-2030
10.3.Asia-Pacific
10.3.1.China
10.3.1.1.Market size analysis, by Product, 2021-2030
10.3.1.2.Market size analysis, by Technique, 2021-2030
10.3.1.3.Market size analysis, by Technology, 2021-2030
10.3.1.4.Market size analysis, by Application, 2021-2030
10.3.1.5.Market size analysis, by End-user, 2021-2030
10.3.2.Japan
10.3.2.1.Market size analysis, by Product, 2021-2030
10.3.2.2.Market size analysis, by Technique, 2021-2030
10.3.2.3.Market size analysis, by Technology, 2021-2030
10.3.2.4.Market size analysis, by Application, 2021-2030
10.3.2.5.Market size analysis, by End-user, 2021-2030
10.3.3.India
10.3.3.1.Market size analysis, by Product, 2021-2030
10.3.3.2.Market size analysis, by Technique, 2021-2030
10.3.3.3.Market size analysis, by Technology, 2021-2030
10.3.3.4.Market size analysis, by Application, 2021-2030
10.3.3.5.Market size analysis, by End-user, 2021-2030
10.3.4.Australia
10.3.4.1.Market size analysis, by Product, 2021-2030
10.3.4.2.Market size analysis, by Technique, 2021-2030
10.3.4.3.Market size analysis, by Technology, 2021-2030
10.3.4.4.Market size analysis, by Application, 2021-2030
10.3.4.5.Market size analysis, by End-user, 2021-2030
10.3.5.South Korea
10.3.5.1.Market size analysis, by Product, 2021-2030
10.3.5.2.Market size analysis, by Technique, 2021-2030
10.3.5.3.Market size analysis, by Technology, 2021-2030
10.3.5.4.Market size analysis, by Application, 2021-2030
10.3.5.5.Market size analysis, by End-user, 2021-2030
10.3.6.Rest of Asia-Pacific
10.3.6.1.Market size analysis, by Product, 2021-2030
10.3.6.2.Market size analysis, by Technique, 2021-2030
10.3.6.3.Market size analysis, by Technology, 2021-2030
10.3.6.4.Market size analysis, by Application, 2021-2030
10.3.6.5.Market size analysis, by End-user, 2021-2030
10.3.7.Research Dive Exclusive Insights
10.3.7.1.Market attractiveness, 2021-2030
10.3.7.2.Competition heatmap, 2021-2030
10.4.LAMEA
10.4.1.Brazil
10.4.1.1.Market size analysis, by Product, 2021-2030
10.4.1.2.Market size analysis, by Technique, 2021-2030
10.4.1.3.Market size analysis, by Technology, 2021-2030
10.4.1.4.Market size analysis, by Application, 2021-2030
10.4.1.5.Market size analysis, by End-user, 2021-2030
10.4.2.Saudi Arabia
10.4.2.1.Market size analysis, by Product, 2021-2030
10.4.2.2.Market size analysis, by Technique, 2021-2030
10.4.2.3.Market size analysis, by Technology, 2021-2030
10.4.2.4.Market size analysis, by Application, 2021-2030
10.4.2.5.Market size analysis, by End-user, 2021-2030
10.4.3.UAE
10.4.3.1.Market size analysis, by Product, 2021-2030
10.4.3.2.Market size analysis, by Technique, 2021-2030
10.4.3.3.Market size analysis, by Technology, 2021-2030
10.4.3.4.Market size analysis, by Application, 2021-2030
10.4.3.5.Market size analysis, by End-user, 2021-2030
10.4.4.South Africa
10.4.4.1.Market size analysis, by Product, 2021-2030
10.4.4.2.Market size analysis, by Technique, 2021-2030
10.4.4.3.Market size analysis, by Technology, 2021-2030
10.4.4.4.Market size analysis, by Application, 2021-2030
10.4.4.5.Market size analysis, by End-user, 2021-2030
10.4.5.Rest of LAMEA
10.4.5.1.Market size analysis, by Product, 2021-2030
10.4.5.2.Market size analysis, by Technique, 2021-2030
10.4.5.3.Market size analysis, by Technology, 2021-2030
10.4.5.4.Market size analysis, by Application, 2021-2030
10.4.5.5.Market size analysis, by End-user, 2021-2030
10.4.6.Research Dive Exclusive Insights
10.4.6.1.Market attractiveness, 2021-2030
10.4.6.2.Competition heatmap, 2021-2030
11.Competitive Landscape
11.1.Top winning strategies, 2021
11.1.1.By strategy
11.1.2.By year
11.2.Strategic overview
11.3.Market share analysis, 2021
12.Company Profiles
12.1. Thermo Fisher Scientific
12.1.1.Overview
12.1.2.Business segments
12.1.3.Product portfolio
12.1.4.Financial performance
12.1.5.Recent developments
12.1.6.SWOT analysis
12.2.F. Hoffmann-La Roche Ltd
12.2.1.Overview
12.2.2.Business segments
12.2.3.Product portfolio
12.2.4.Financial performance
12.2.5.Recent developments
12.2.6.SWOT analysis
12.3.Abbott
12.3.1.Overview
12.3.2.Business segments
12.3.3.Product portfolio
12.3.4.Financial performance
12.3.5.Recent developments
12.3.6.SWOT analysis
12.4. BD
12.4.1.Overview
12.4.2.Business segments
12.4.3.Product portfolio
12.4.4.Financial performance
12.4.5.Recent developments
12.4.6.SWOT analysis
12.5.BIOMÉRIEUX
12.5.1.Overview
12.5.2.Business segments
12.5.3.Product portfolio
12.5.4.Financial performance
12.5.5.Recent developments
12.5.6.SWOT analysis
12.6.Cepheid.
12.6.1.Overview
12.6.2.Business segments
12.6.3.Product portfolio
12.6.4.Financial performance
12.6.5.Recent developments
12.6.6.SWOT analysis
12.7.Luminex Corporation
12.7.1.Overview
12.7.2.Business segments
12.7.3.Product portfolio
12.7.4.Financial performance
12.7.5.Recent developments
12.7.6.SWOT analysis
12.8.Accelerate Diagnostics
12.8.1.Overview
12.8.2.Business segments
12.8.3.Product portfolio
12.8.4.Financial performance
12.8.5.Recent developments
12.8.6.SWOT analysis
12.9.AdvanDX
12.9.1.Overview
12.9.2.Business segments
12.9.3.Product portfolio
12.9.4.Financial performance
12.9.5.Recent developments
12.9.6.SWOT analysis
12.10.Bruker
12.10.1.Overview
12.10.2.Business segments
12.10.3.Product portfolio
12.10.4.Financial performance
12.10.5.Recent developments
12.10.6.SWOT analysis
13.Appendix
13.1.Parent & peer market analysis
13.2.Premium insights from industry experts
13.3.Related reports
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer